HK Stock Market Move | SIHUAN PHARM(00460) rose more than 4% in the afternoon, turning a loss into a profit of 103 million yuan in the first half of the year, with a significant increase in revenue from its medical beauty business.

SIHUAN PHARM(00460) rose more than 4% in the afternoon, rising 4.17% by the time of publication, to 1.5 Hong Kong dollars, with a turnover of 1.09 billion Hong Kong dollars. On the news front, SIHUAN PHARM announced its mid-term performance for 2025 at noon, with a revenue of 1.146 billion yuan, an increase of 20.69% year-on-year; shareholders' profit amounted to 103 million yuan, turning losses into profits year-on-year; it plans to distribute a mid-term cash dividend of 0.99 cents per share. The change in income during the period was mainly driven by the income from the medical beauty business, which amounted to approximately 585 million yuan, an increase of about 81.3% year-on-year. This was mainly due to the significant success in strategic cooperation between the group's medical beauty platform, MYSPACE, and multiple medical beauty institutions, as well as the successful promotion of the marketing strategy 3.0 version. The products have been highly recognized by the market, leading to a substantial increase in medical beauty sales revenue. During the period, MYSPACE achieved further breakthroughs in the field of regenerative medicine, with two self-developed regenerative injection products - injectable polycaprolactone microspheres facial filler (Youth Injection) and polylactic acid facial filler (Youthful Injection) - both approved for listing.